MEPROBAMATE vs MEROPENEM ANHYDROUS: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
MEPROBAMATE vs MEROPENEM ANHYDROUS: Safety Overview
| Metric | MEPROBAMATE | MEROPENEM ANHYDROUS |
|---|---|---|
| Total FAERS Reports | 427 | 144 |
| Deaths Reported | 320 | 25 |
| Death Rate | 74.9% | 17.4% |
| Hospitalizations | 55 | 102 |
| Average Patient Age | 44.8 yrs | 55.0 yrs |
| % Female Patients | 54.6% | 44.2% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | N/A |
| Manufacturer | Cipla USA Inc. | Mylan Institutional LLC |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | N/A |